Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05955482 · ClinicalTrials.gov registry record

Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease

A clinical trial of COPD and Comorbidities and Coexisting Conditions, sponsored by NuvoAir Medical PC.

Active
Registry status
300
Enrollment target
1
Study location

NCT05955482 is a study of COPD and Comorbidities and Coexisting Conditions that is active but no longer recruiting, run by NuvoAir Medical PC. The registered enrollment target is 300 participants, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05955482, a study of COPD and Comorbidities and Coexisting Conditions, is active but no longer recruiting, sponsored by NuvoAir Medical PC.

ACTIVE NOT RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

This is a 12 month study of up to 500 people with COPD to determine if the NuvoAir clinical service leads to lower rates of severe COPD exacerbations, hospitalizations, emergency room visits, and total cost of care compared to a similar group that doesn't receive care from the NuvoAir clinical service.

Interventions

  • OTHER NuvoAir Clinical Service

Study Locations (1)

Wisconsin

  • Marshfield Clinic Research Institute - Marshfield

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-07-24
Est. Completion 2025-07

Sponsor

NuvoAir Medical PC

1 total trials

What the Registry Record Tells You About NCT05955482

The ClinicalTrials.gov registry entry for NCT05955482 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower). The listed sponsor is NuvoAir Medical PC, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which NuvoAir Clinical Service is the first listed.

NCT05955482 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05955482 about?

NCT05955482 is a clinical study titled "Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease". This is a 12 month study of up to 500 people with COPD to determine if the NuvoAir clinical service leads to lower rates of severe COPD exacerbations, hospitalizations, emergency room visits, and total cost of care compared to a similar group that doesn't receive care from the NuvoAir clinical servi...

What is the current status of trial NCT05955482?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2023-07-24. Estimated completion is 2025-07.

What conditions does trial NCT05955482 study?

This clinical trial studies the following conditions: COPD, Comorbidities and Coexisting Conditions.

What interventions are being tested in trial NCT05955482?

The interventions under investigation include: NuvoAir Clinical Service (OTHER).

Who is sponsoring clinical trial NCT05955482?

This trial is sponsored by NuvoAir Medical PC, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05955482 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.